Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/25131
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSaip, Pınar Mualla-
dc.contributor.authorKeskin, Serkan-
dc.contributor.authorÖzkan, Metin-
dc.contributor.authorKaplan, Muhammet Ali-
dc.contributor.authorAydoǧan, Fatma-
dc.contributor.authorGönüllü Demirağ, Güzin-
dc.contributor.authorUzunoǧlu, Sernaz-
dc.contributor.authorEngin, Hüseyin Bülent-
dc.contributor.authorBaşaran, Gül Atalay-
dc.contributor.authorGü̈ler, Nilüfer E.-
dc.contributor.authorUygun, Kazım M.-
dc.contributor.authorDemirkan, Binnaz Hatice Miraç-
dc.contributor.authorÖzdemir, Feyyaz-
dc.contributor.authorSalepçi, Taflan-
dc.contributor.authorÇiçin, İrfan-
dc.date.accessioned2022-03-17T10:44:26Z-
dc.date.available2022-03-17T10:44:26Z-
dc.date.issued2011-
dc.identifier.citationSaip, P. vd. (2011). "The access rate to diagnosis and treatment modalities in breast cancer patients in Turkey; Multicenter observational study". Journal of BUON, 16(4), 664-671.en_US
dc.identifier.issn1107-0625-
dc.identifier.issn2241-6293-
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/22331719/-
dc.identifier.urihttp://hdl.handle.net/11452/25131-
dc.description.abstractPurpose: To determine the time elapsed between the first notification of the disease and the access to the diagnosis and treatment modalities and the associated factors in female patients with breast cancer in Turkey. Methods: Data was acquired from a questionnaire involving 535 patients who applied to 14 various oncology clinics in Turkey between 1st and 28th of February 2010. Analyses were performed by the participating clinics and were divided into 3 groups: centers located in metropolitan areas formed group I (n=161), those located in Marmara and central Anatolia region formed group 2 (n=189), and centers located in Karadeniz and East-Southeast Anatolia region formed group 3 (n=185). The groups of these centers were formed according to the socioeconomic development of the provinces. Results: The median patient age was 48 years, 56.1% of patients were less than 50 years of age. Eighty-five percent of the patients detected a mass in their breast by self examination and 27% of the patients older than 50 years never had breast imaging until the definite diagnosis was established. The median time elapsed between disease noticed by the patient and application to a health care center was 10 days, between application and biopsy 19 days, between biopsy and surgery 10 days, and between surgery and systemic therapy 31 days. The median time elapsed between patients applying for surgery in groups I and 2 centers was 11 and 21 days, respectively (p=0.01). The median time elapsed between biopsy and surgery in groups 1,2 and 3 centers was 14,1.5, and 12 days, respectively (p<0.05). Conclusion: A high level of awareness regarding breast cancer in our country is related with the time that is defined as 10 days between disease recognition and medical application. The time elapsed between the application and biopsy, surgery and systemic therapy was longer compared with the corresponding figures in developed countries.en_US
dc.language.isoenen_US
dc.publisherImprimatur Publicationsen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOncologyen_US
dc.subjectBreast canceren_US
dc.subjectElapsed time to diagnosis and treatmenten_US
dc.subjectSocioeconomic factorsen_US
dc.subject1st adjuvant therapyen_US
dc.subjectWaiting timeen_US
dc.subjectChemotherapyen_US
dc.subjectSurvivalen_US
dc.subjectDelayen_US
dc.subject.meshBreast neoplasmsen_US
dc.subject.meshFemaleen_US
dc.subject.meshHealth services accessibilityen_US
dc.subject.meshHumansen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshQuestionnairesen_US
dc.subject.meshSocioeconomic factorsen_US
dc.subject.meshSurvival rateen_US
dc.subject.meshTurkeyen_US
dc.titleThe access rate to diagnosis and treatment modalities in breast cancer patients in Turkey; Multicenter observational studyen_US
dc.typeArticleen_US
dc.identifier.wos000298717200012tr_TR
dc.identifier.scopus2-s2.0-84855433624tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı.tr_TR
dc.identifier.startpage664tr_TR
dc.identifier.endpage671tr_TR
dc.identifier.volume16tr_TR
dc.identifier.issue4tr_TR
dc.relation.journalJournal of BUONen_US
dc.contributor.buuauthorÇubukçu, Erdem-
dc.relation.collaborationYurt içitr_TR
dc.identifier.pubmed22331719tr_TR
dc.subject.wosOncologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ4en_US
dc.contributor.scopusid53986153800tr_TR
dc.subject.scopusCancer Patients; Adjuvant Chemotherapy; Time to Treatmenten_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAge distributionen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeAwarenessen_US
dc.subject.emtreeBreast biopsyen_US
dc.subject.emtreeBreast canceren_US
dc.subject.emtreeCancer diagnosisen_US
dc.subject.emtreeCancer patienten_US
dc.subject.emtreeCancer surgeryen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeDiagnostic imagingen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeGeographic distributionen_US
dc.subject.emtreeHealth centeren_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeObservational studyen_US
dc.subject.emtreeQuestionnaireen_US
dc.subject.emtreeSelf examinationen_US
dc.subject.emtreeSocioeconomicsen_US
dc.subject.emtreeSystemic therapyen_US
dc.subject.emtreeTimeen_US
dc.subject.emtreeTurkey (republic)en_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.